banner

Stocks Gallop Home with Earnings in Focus

Dow Jones October 15 2012

Stocks moved higher Monday as investors welcomed a sharp rise in retail sales and better-than-expected quarterly earnings from Citigroup.

The Dow Jones Industrial average leaped 95.38 points to close at 13,424.20

The S&P 500 prospered 11.54 points to 1,440.13, while the tech-rich Nasdaq recovered 20.07 points to 3,064.18

Bank stocks were among the best performers after Citigroup reported third-quarter earnings that topped analysts’ forecasts. Shares of Citi rose about 4%. Bank of America and JPMorgan were also higher.

American International Group was the best insurance play today with a 1.6% advance.

Shares of Cablevision paced S&P 500 performers with a 4.85% climb, riding the news from last week that it is considering selling Bresnan Broadband Holdings LLC, a provider of TV and internet services.

On the other side of the coin, shares of MetroPCS Communications lead the S&P 500 laggards with a 4.9% decline as investors realize that the company – which is in the midst of a merger itself with T-Mobile – will have to compete with a stronger Sprint Nextel now that Japan’s Softbank is taking a major position in the company.

Sprint agreed to sell a 70 percent stake of itself to Softbank Corp. in a deal valued at $20.1 billion. Clearwire Corp., who has Sprint as a large shareholder, continued to leg upward on the news.

Among the blue chips reporting results this week are Intel, Bank of America, IBM and Johnson & Johnson

Eli Lilly shares rose after the pharmaceutical company said a study of its gastric cancer drug showed positive results.

Shares of rival drug maker Abbott rose after it announced upbeat results for an initial study of its treatment of hepatitis C.

Yahoo Inc. saw its shares demur 1.1% after Stifel Nicolaus lowered its Q3 earnings estimates for the online media company from 28 cents per share to 23 cents per share.



Texas Instruments shares gained on speculation that Amazon is in talks to buy its smartphone microchip business.

Shares of Workday, which made a strong NYSE debut last week, kept their upward trajectory by rising another 6.67% to $51.94.

Shares of toy maker Hasbro fell more than 2% after analysts at Goldman Sachs downgraded the stock to sell. Goldman cited a sharp decline in the amount of money consumers spend on toys and games. Shares of rival toy company Mattel sympathetically fell as well.

Media conglomerate Gannett and brokerage Charles Schwab both reported earnings that beat forecasts.

Economically speaking, retail sales jumped 1.1% in September, boosted by higher gas prices and electronic sales, according to the U.S. Census Bureau. That’s higher than the 0.7% rise expected by analysts.

The Federal Reserve Bank of New York’s monthly Empire State Manufacturing Index remained in negative territory in October, but improved to a reading of -6.2 compared to a reading of -10.4 in September.

Overseas, a report Monday showed that inflation in China slowed in September. Chinese consumers paid 1.9% more for goods in September than they did a year earlier, the government’s National Bureau of Statistics reported. That’s down from a 2% increase in August.

The price of the benchmark 10-year U.S. Treasury was unchanged on the day, keeping the yield at Friday’s 1.66%.

Oil prices recovered from lows, but still slipped 22 cents to $91.64 U.S. a barrel.

Gold prices fell $21.10 to $1,738.60 U.S. an ounce.

Dow Jones Industrial Average (DJIA) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Mixed on Monday

Stocks Mixed on Monday(0)

The Dow Jones industrial average topped 16,000 for the first time ever Monday, while the S&P 500 briefly surpassed 1,800. The Dow retreated from the 16,000 level, but still gained 14.32 points from Friday”s all-time high close, to 15,976. The S&P 500 index dipped 6.65 points to 1,791.53. The NASDAQ fell 36.90 points to 3,949.07

Catalyst Pharmaceutical Partners Stock Chart Analysis Video

Catalyst Pharmaceutical Partners Stock Chart Analysis Video(0)

The Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock chart formed a piercing line reversal pattern on Wednesday and Thursday that was confirmed with a sharp move upwards on Friday. Technical traders will be watching support around the 200 day moving average at $1.25 on any pullback, but for the time being, the chart looks to be

EnteroMedics Stock Chart Analysis Video

EnteroMedics Stock Chart Analysis Video(0)

The EnteroMedics (NASDAQ:ETRM) chart has been making higher highs and higher lows since forming a double bottom early in the year. The chart is holding over the 50-day moving average and inching higher each day as it tries to gain momentum to make the next leg up in the channel. EnteroMedics is a medical device

NXT-ID Authentication Using Face and Voice Recognition

NXT-ID Authentication Using Face and Voice Recognition(0)

There’s a Wocket in My Pocket! may soon not just be a sentence from the mouths of children after reading the rhyming book by Dr. Seuss. There was plenty of made-up ridiculousness in the iconic book, such as a bofa on the sofa, but there is nothing fictitious about the Wocket, a next-generation payment and

Dow Not Tired of Making New Record Highs

Dow Not Tired of Making New Record Highs(0)

The Dow Jones Industrials will have to wait till at least next week to mount the lofty heights of 16,000 points, but both the Dow and the S&P did end the day at record highs. The Dow Jones Industrials was up 85.48 points from yesterday”s all-time high, to close at 15,961.70 The S&P 500 index

read more
banner

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.